Multiple Myeloma medications
In this page you will find the list of drugs approved by the FDA to treat Multiple Myeloma.
belantamab mafodotin  (Blenrep)
 Antibody-Drug Conjugates
Learn More arrow_right_alt
bortezomib  (Velcade)
 Proteasome Inhibitors
Learn More arrow_right_alt
carfilzomib  (Kyprolis)
 Proteasome Inhibitors
Learn More arrow_right_alt
ciltacabtagene autoleucel  (Carvykti)
 CAR-T Cell Therapy
Learn More arrow_right_alt
daratumumab  (Darzalex)
 Monoclonal Antibodies
Learn More arrow_right_alt
dexamethasone  (Decadron)
 Systemic Steroids
Learn More arrow_right_alt
doxorubicin  (Adriamycin, Doxil)
 Chemotherapy Agents
Learn More arrow_right_alt
elotuzumab  (Empliciti)
 Monoclonal Antibodies
Learn More arrow_right_alt
Elranatamab  (Elrexfio)
 Bispecific Antibodies
Learn More arrow_right_alt
ibrutinib  (Imbruvica)
 Tyrosine Kinase Inhibitors
Learn More arrow_right_alt
Idecabtagene Vicleucel  (Abecma)
 CAR-T Cell Therapy
Learn More arrow_right_alt
isatuximab  (Sarclisa)
 Monoclonal Antibodies
Learn More arrow_right_alt
ixazomib  (Ninlaro)
 Proteasome Inhibitors
Learn More arrow_right_alt
lenalidomide  (Revlimid)
 Immunomodulatory Agents
Learn More arrow_right_alt
nivolumab  (Opdivo)
 Monoclonal Antibodies
Learn More arrow_right_alt
pembrolizumab  (Keytruda)
 Monoclonal Antibodies
Learn More arrow_right_alt
pomalidomide  (Pomalyst)
 Immunomodulatory Agents
Learn More arrow_right_alt
rituximab  (Riabni, Rituxan, Ruxience, Truxima)
 Monoclonal Antibodies
Learn More arrow_right_alt
selinexor  (Xpovio)
 Selective Inhibitor of Nuclear Export
Learn More arrow_right_alt
talquetamab  (Talvey)
 Bispecific Antibodies
Learn More arrow_right_alt
teclistamab  (Tecvayli)
 Bispecific Antibodies
Learn More arrow_right_alt
thalidomide  (Thalomid)
 Immunomodulatory Agents
Learn More arrow_right_alt
venetoclax  (Venclexta)
 Targeted Therapy
Learn More arrow_right_alt